PneumRx, BTG deal

BTG will acquire pulmonary device maker PneumRx for €186 million ($230 million) up

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE